CRIXIVAN

LOE Approaching

indinavir sulfate

NDAORALCAPSULEPriority Review
Approved
Mar 1996
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
4

Mechanism of Action

Mechanism of Action: HIV-1 protease is an enzyme required for the proteolytic cleavage of the viral polyprotein precursors into the individual functional proteins found in infectious HIV-1. Indinavir binds to the protease active site and inhibits the activity of the enzyme. This inhibition prevents…

Indications (1)

Clinical Trials (4)

NCT00002354N/ACompleted

A Study of Indinavir Sulfate Given Together With Stavudine to HIV-Positive Patients

540 enrolled
HIV Infections
NCT00002208Phase 3Completed

A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate, 800 Mg q 8 h Versus 1,200 Mg q 12 h in Combination With Zidovudine and 3TC

400 enrolled
HIV Infections
NCT00002369N/ACompleted

A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

200 enrolled
HIV Infections
NCT00002387N/ACompleted

The Safety and Effectiveness of Indinavir Sulfate Plus Efavirenz

80 enrolled
HIV Infections